Citadel Advisors’s MedEquities Realty Trust, Inc. MRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-10,919
Closed -$75K 10241
2018
Q4
$75K Sell
10,919
-25,881
-70% -$203K ﹤0.01% 8373
2018
Q3
$358K Buy
36,800
+7,314
+25% +$77.5K ﹤0.01% 7285
2018
Q2
$325K Buy
29,486
+13,284
+82% +$137K ﹤0.01% 7082
2018
Q1
$170K Sell
16,202
-12,959
-44% -$138K ﹤0.01% 7461
2017
Q4
$327K Buy
29,161
+2,646
+10% +$30K ﹤0.01% 6319
2017
Q3
$312K Buy
+26,515
New +$314K ﹤0.01% 6012
2017
Q2
Sell
-30,709
Closed -$344K 8393
2017
Q1
$344K Buy
+30,709
New +$343K ﹤0.01% 5673

Other funds holding MRT

Citadel Advisors's MRT Position: Q1 2019 in Review

Citadel Advisors sold out of MedEquities Realty Trust, Inc. (MRT) in Q1 2019, closing a stake of 10,919 shares — an estimated $75K sold.

Citadel Advisors first reported a position in MRT in Q1 2017 and held it in 7 quarters. The position peaked at $358K in Q3 2018. 103 funds tracked by Wall St. Rank hold MRT as of Q1 2019.

  • Citadel Advisors reported no remaining MedEquities Realty Trust, Inc. position as of Q1 2019 after selling out during the quarter.
  • Citadel Advisors sold 10,919 MedEquities Realty Trust, Inc. shares in Q1 2019, an estimated $75K.
  • Citadel Advisors first reported a position in MedEquities Realty Trust, Inc. in Q1 2017 and held it in 7 quarters.
  • Citadel Advisors's MedEquities Realty Trust, Inc. position peaked at $358K in Q3 2018.
  • 103 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q1 2019.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.